Hemophilia
Blood-Immune-Related: FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts
The condition, which usually develops in adults, is known as chronic immune thrombocytopenic purpura (ITP), a disease that results in a low number of platelets...
Date:
08/22/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01876.html
VIDEO-Blood clotting
When a small artery is cut, the collagen fibers in its tissue are exposed, which signals clotting process to begin.
Date:
07/02/2008
, Publication:
Univ of Penn Health System
, Author:
Univ of Penn Health System
http://www.pennhealth.com/health_info/animationplayer/clotting.html
FDA Approves New Formulation of Coagulation Therapy
NovoSeven RT Can Be Stored at Room Temperature
Date:
05/09/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01833.html
FDA Licenses New Hemophilia Treatment
The U.S. Food and Drug Administration today licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.
Date:
02/22/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01799.html
FDA Approves Change in Storage Conditions for Humate-P
The U.S. Food and Drug Administration today approved a change in the storage conditions for Humate-P, a treatment for bleeding in certain patients with hemophilia A or von Willebrand Disease (vWD).
Date:
10/19/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01731.html
Higher Medicare reimbursement for infusion pump
Users of the Freedom60 infusion pump from Repro-Med Systems Inc. DBA RMS Medical Products are now entitled to receive 20 times the Medicare reimbursement previously offered
Date:
06/25/2007
, Publication:
Drug Topics
, Author:
Hot Off the Press
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=436912
FDA Clears 'Computerized Medication Box' for U.S. Market
FDA has cleared for marketing the INRange Systems' Electronic Medication Management Assistant (EMMA), a programmable device that stores and dispenses prescription medication for patients' use in the home.
Date:
06/21/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01655.html
Home Infusion Therapy Gets Patients Out of the Hospital
Individuals who receive home treatment include patients with infections that require intravenous (IV) medications, patients with cancer who need chemotherapy, and patients with severe pain who require intraspinal or IV medications.
Date:
06/08/2007
, Publication:
Pharmacy Times
, Author:
Eileen Koutnik-Fotopoulos, Staff Writer
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4678
Bleeding-FDA Approves Product to Treat Common Bleeding Disorder
...approved Humate-P (Antihemophilic Factor/von Willebrand Factor Complex) for the prevention of excessive bleeding during and after surgery in certain patients with mild to moderate and severe von Willebrand disease
Date:
04/27/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01619.html
FDA Clears Baxter's Modified Infusion Pump
Pump was subject of recalls and seizure actions in 2005
Date:
02/27/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01571.html
Previous
Page 1 of 4
Next >
Search returned 31 items.
|
Sponsored Links
Clinical Researchers, others from
subscriber lists and assoc's.
www.biotechmedia.com
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
This is a "how to" magazine
for pediatric clinicians
www.contemporarypediatrics.com
|